US 9,809,544 B2
KCNQ2-5 channel activator
Kentaro Yashiro, Osaka (JP); Daisuke Wakamatsu, Osaka (JP); and Tetsuji Saito, Osaka (JP)
Assigned to Ono Pharmaceutical Co., Ltd., Osaka (JP)
Appl. No. 15/515,243
Filed by Ono Pharmaceutical Co., Ltd., Chuo-ku, Osaka-shi, Osaka (JP)
PCT Filed Oct. 23, 2015, PCT No. PCT/JP2015/080034
§ 371(c)(1), (2) Date Mar. 29, 2017,
PCT Pub. No. WO2016/063990, PCT Pub. Date Apr. 28, 2016.
Claims priority of application No. 2014-217540 (JP), filed on Oct. 24, 2014.
Prior Publication US 2017/0217888 A1, Aug. 3, 2017
Int. Cl. C07D 213/61 (2006.01)
CPC C07D 213/61 (2013.01) 2 Claims
 
1. 1-[(5-chloro-2-pyridinyl)methyl]-3-{2,6-dichloro-4-[(2S)-1,1,1-trifluoro-2-hydroxy-2-propanyl]phenyl}urea, or
a pharmaceutically acceptable salt thereof.